Author:
Selle F.,Sevin E.,Ray-Coquard I.,Mari V.,Berton-Rigaud D.,Favier L.,Fabbro M.,Lesoin A.,Lortholary A.,Pujade-Lauraine E.
Reference24 articles.
1. European International Agency for Research on Cancer. Cancer Fact Sheet, Ovarian Cancer; http://eco.iarc.fr/EUCAN/CancerOne.aspx?Cancer=27&Gender=2 (November 2013, date last accessed)
2. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference;Stuart;Int J Gynecol Cancer,2011
3. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J Clin Oncol,2012
4. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer;Ledermann;N Engl J Med,2012
5. Ovarian and papillary-serous peritoneal carcinoma: pilot study with thalidomide;Abramson;J Clin Oncol,2002
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献